Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2017 / Cilt: 51 - Sayı: 1

Factors affecting the development of scar formation in abdominal surgery performed for gynecologic and obstetric conditions

Jinekolojik ve obstetrik nedenli abdominal cerrahilerde skar gelişimini etkileyen faktörler

Pages
12–17
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no significant difference between the groups for the risk of hypertrophic scar formation (p>0.05).Conclusion: Our study concluded that there is no significant difference in scar formation on abdominal incision site between benign gynecologic surgeries performed at any period of childbearing age and cesarean section.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: The aim of this study is to investigate whether there can be a difference in types of scars developed on the same type of incisions due to cesarean section or benign gynecologic operations, and to examine the effect of regenerative process occurring in the puerperal period on scar formation.
📊
Key Findings & Data:Materials and Methods: A total of 586 female patients aged 20-40 years, who applied to our dermatology and gynecology and obstetrics outpatient clinics, were included in this case control study.
💡
Conclusion & Impact:There was no significant difference between the groups for the risk of hypertrophic scar formation (p>0.05).Conclusion: Our study concluded that there is no significant difference in scar formation on abdominal incision site between benign gynecologic surgeries performed at any period of childbearing age and cesarean section.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: The aim of this study is to investigate whether there can be a difference in types of scars developed on the same type of incisions due to cesarean section or benign gynecologic operations, and to examine the effect of regenerative process occurring in the puerperal period on scar formation. Materials and Methods: A total of 586 female patients aged 20-40 years, who applied to our dermatology and gynecology and obstetrics outpatient clinics, were included in this case control study. Patients who were operated due to benign gynecologic conditions were assigned to group 1 (n=293), and those who underwent cesarean section to group 2 (n=293), and the types of scars were compared. A p value of less than 0.05 was considered statistically significant.Results: Atrophic and hypertrophic scars were developed in 237 (80.9%) and 56 (19.1%) of group 1 patients, respectively. However, 245 (83.6%) of patients in group 2 had atrophic scars and 48 (16.4%) had hypertrophic scars. In terms of the type of scar distribution, no significant difference was found between the two groups (p>0.05). Patients with hypertrophic scar formation constituted 53.8% of group 1 patients and 46.2% of group 2 patients. There was no significant difference between the groups for the risk of hypertrophic scar formation (p>0.05).Conclusion: Our study concluded that there is no significant difference in scar formation on abdominal incision site between benign gynecologic surgeries performed at any period of childbearing age and cesarean section. In addition, the presence of striae, wound infection or hematoma, and duration of wound healing were found to be associated with the risk for hypertrophic scar formation in incision sites in both cesarean section and benign gynecological operations

Özet

Amaç: Bu çalışmanın amacı benign jinekolojik operasyonlar veya sezaryen nedeniyle uygulanan aynı tipteki insizyonlarda gelişen skar tiplerinin birbirinden farklı olup olmadığının araştırılması ve puerperal dönemde oluşan rejeneratif sürecin skar gelişimi üzerine etkisi olup olmadığının incelenmesidir.Gereç ve Yöntem: Bu olgu kontrol çalışmasında üniversitemiz Dermatoloji ve Kadın Hastalıkları ve Doğum polikliniklerine başvuran, 20-40 yaş aralığında toplam 586 kadın çalışmaya dahil edildi. Hastalar benign jinekolojik nedenlerle operasyon geçirenler (grup 1) ve sezaryen geçirenler (grup 2) olmak üzere iki gruba ayrıldı. Veriler skar tiplerine göre karşılaştırıldı. İstatistiksel anlamlılık için 0,05'ten küçük p değerleri anlamlı kabul edildi. Bulgular: Benign jinekolojik nedenlerle operasyon geçiren 293 hastanın 237'sinde (%80,9) atrofik, 56'sında (%19,1) hipertrofik tipte skar gelişirken sezaryen operasyonu geçiren 293 hastanın 245'inde (%83,6) atrofik, 48 (%16,4) hastada hipertrofik tipte skar geliştiği saptandı. Skar tiplerinin dağılımı açısından gruplar arasında istatistiksel olarak anlamlı fark saptanmadı (p>0,05). Hipertrofik tipte skar gelişen hastaların %53,8'inin grup 1'de %46,2'sinin grup 2'de olduğu saptandı. Hipertrofik tipte skar gelişim riski açısından gruplar arasında istatistiksel olarak anlamlı fark saptanmadı (p>0,05). Sonuç: Çalışmamızda gebelikte uygulanan sezaryen operasyonu ile doğurganlık çağının herhangi bir döneminde uygulanan benign jinekolojik operasyonlar arasında abdominal insizyon yerinde skar oluşumu açısından anlamlı fark olmadığı sonucuna varılmıştır. Sezaryen operasyonu ve benign jinekolojik operasyonlar sonrasında insizyon yerinde hipertrofik skar gelişimi açısından daha önceden stria varlığı, yara yerinde enfeksiyon veya hematom gelişmesi, yara iyileşmesi süresinin on günden uzun olması gibi faktörlerin benzer oranda risk oluşturduğu tespit edildi

🔖

Cite This Article

KELEKÇİ, K. H., AYDOĞMUŞ, S., DESDİCİOĞLU, R., KELEKÇİ, S., ŞENGÜL, M., KARACA, Ş., DEMİREL, E. (2022). Factors affecting the development of scar formation in abdominal surgery performed for gynecologic and obstetric conditions. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 51 - Sayı: 1, 12–17. https://ajindex.com/articles/621706

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Gurtner GC, Werner S, Barrandon Y, Longaker MT: Wound repair and regeneration. Nature 2008;453:314-21
  2. Seifert O, Mrowietz U: Keloid scarring: bench and bedside. Arch Dermatol Res 2009;301:259-72
  3. English RS, Shenefelt PD: Keloids And Hypertrophic Scars. Dermatol Surg 1999;25:631-8
  4. Sherwood OD: Relaxin’s physiological roles and other diverse actions. Endocr Rev 2004;25:205-34
  5. Unemori EN, Amento EP: Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 1990;265:10681-5
  6. Huang X, Arnold G, Lewis M, Guzman L, Grove BH, Unemori EN, Zsebo K: Effect of relaxin on normal and impaired wound healing in rodents. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands. Kluwer Academic Publishers;393-7
  7. Martin AG, Leal-Khouri S: Physiologic skin changes associated with pregnancy. Int J Dermatol 1992;31:375-8
  8. Midgley AR Jr, Jaffe RB: Regulation of human gonadotropins. II. Disappearance of human chorionic gonadotropin following delivery. J Clin Endocrinol Metab 1968;28:1712-8
  9. Resnik, R: The Puerperium. In: Maternal Fetal-Medicine, Principles and Practice, Creasy, RK, Resnik, R (Eds), W.B. Saunders, Philadelphia 2004:165
  10. Tziotzios C, Profyris C, Sterling J: Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics. Part II. Strategies to reduce scar formation after dermatologic procedures. J Am Acad Dermatol 2012;66:13-24;quiz 25-6
  11. Sherris DA, Larrabee WF Jr, Murakami CS: Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 1995;28:1057- 6 12. Guo S, Dipietro LA: Factors affecting wound healing. J Dent Res 2010;89:219- 29
  12. Hardman MJ, Aschoft GS: Estrogen, not intrinsic aging, is the major regulator of delayed human wound healing in the elderly. Genome Biol 2008;9:80
  13. Shu YY, Maibach HI: Estrogen and Skin Therapeutic Options. Am J Clin Dermatol 2011;12:297-311
  14. Ashcroft GS, Mills SJ, Lei K, et al: Estrogen modulates cutaneous wound healing by down regulating macrophage migration inhibitory factor. J Clin Invest 2003;111:1309-18
  15. Foitzik K, Langan EA, Paus R: Langan and Ralf Paus. Prolactin and the Skin: A dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol 2009;129:1071-87
  16. Lam MT, Nauta A, Meyer NP, et al: Effective delivery of stem cells using an extracellular matrix patch results in increased cell survival